Bookmark
Forward
Clinical cfficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension].
M L Maksimov, A I Malykhina
Kardiologiia 2013
Sizes of these terms reflect their relevance to your search.
The review describes the classification, mechanisms of action, the effects of calcium channel blockers slow and the clinical benefits of dihydropyridine calcium antagonists, the third generation. Presented modern aspects of clinical pharmacology and research results on the efficacy, safety and organoprotective lercanidipine.
Citation
M L Maksimov, A I Malykhina.
Clinical cfficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension].
Kardiologiia.
2013;53(6):85-90
Mesh Tags
Antihypertensive Agents
Calcium Channel Blockers
Calcium Channels, L-Type
Dihydropyridines
Drug Therapy, Combination
Humans
Hypertension
Medication Therapy Management
Outcome Assessment (Health Care)
Protective Agents
Treatment Outcome
Substances
Antihypertensive Agents
Calcium Channel Blockers
Calcium Channels, L-Type
Dihydropyridines
Protective Agents
lercanidipine
PMID: 23953051
View Full Text